- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
After Years, Healthcare Spending Is on the Rise
The national medical bill may be back to growing faster than gross domestic product. After 5 years of historically slow growth, new data show US healthcare spending accelerated significantly in 2014.
The national medical bill may be back to growing faster than gross domestic product. After 5 years of historically slow growth, new data show US healthcare spending accelerated significantly in 2014.
The analysis, from the Altarum Institute research group and based on preliminary government data, shows health spending increasing by 5% last year, compared to 3.6% in 2013. If confirmed by the final tally, healthcare spending during 2014 would mark the biggest jump since before the recession.
Economists don't know how much of the recent slowdown was due to the recession and how much came from real changes to the healthcare payments and delivery system.
Read more at Bloomberg Business: http://bloom.bg/1vkkWVd
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
